|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis 显示文摘 | Petros AM Dinges J Augeri DJ | 2006 | J Med Chem2006，49，2： | 1 |
| 2 | Discovery of a potent inhibitor of the an tiapoptotic protein Bcl-XL from NMR and paralle 1 synthesis显示文摘 | Petros AM Dinges J Augeri DJ | 2006 | J Med Chem2006，49，： | 1 |
| 3 | Discovery and preclinicalprofile of Saxagliptin(BMS-477118): a highly potent, long-acting, orallyactive dipeptidyl peptidase IV inhibitor for the treatment of type 2diabetes显示文摘 | Augeri DJ Robl JA Betebenner DA | 2005 | Journal of Medicinal Chemistry2005，48，15： | 1 |
| 4 | Discovery and preclinical profile of Saxagliptin (BMS-477118) : a highly potent, long-acting, orally active dipeptidyl peptidase Ⅳ inhibitor for the treatment of type 2 diabetes显示文摘 | AUGERI DJ ROBL JA BETEBENNER DA | 2005 | J Med Chem2005，48，15： | 1 |
| 5 | Discovery and preclinical profile of Saxagliptin(BMS-477118):a highly potent,long-acting,orally active dipeptidy1 peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘 | AUGERI DJ ROBL JA BETEBENNER DA | 2005 | J Med Chem2005，48，15： | 1 |
| 6 | Discovery and pre-clinical profile of saxagliptin (BMS-477118):a highly potent,long-acting,orally active dipeptidyl peptidaseIVinhibitor for the treatment of type 2 diabetes 显示文摘 | Augeri DJ Robl JA Betebenner DA | 2005 | J Med Chem2005，48，15： | 1 |
| 7 | Discovery and preclinical profile of saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘 | Augeri DJ Robl JA Betebenner DA | 2005 | J Med Chem2005，48，15： | 1 |
| 8 | Discovery and preclinieal profile of Saxagliptin ( BMS-477118 ) : a highly potent, long-acting, orally active dipeptidyl pepti- dase IV inhibitor for the treatment of type 2 diabetes 显示文摘 | Augeri DJ Robl JA Betebenner DA | 2005 | J Med Chem2005，48，15： | 1 |
| 9 | Discovery and preclinical profile of saxagliptin(BMS-477118):a highly potent,long-acting,orally active dipeptidyl peptidaseⅣinhibitor for the treatment of type 2 diabetes显示文摘 | Augeri DJ Robl JA Betebenner DA | 2005 | J Med Chem2005，48，15： | 1 |
| 10 | Discovery and preclinical profile of Saxagliptin (BMS-477118 ) :a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes 显示文摘 | Augeri DJ Robl JA Betebenner DA | 2005 | J Med Chem2005，48，15： | 1 |
| 11 | Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes显示文摘 | Augeri DJ Robl JA Betebenner DA | 2005 | J Med Chem2005，48，15： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员